PSORS2 markers are not associated with psoriatic arthritis in the Italian population

Human Heredity

Volumn 61, Issue 2, 2006, Pages 120-122

  Giardina, Emiliano ^a,i   Predazzi, Irene ^a   Sinibaldi, Cecilia ^a   Peconi, Cristina ^a   Amerio, Paolo ^b   Costanzo, Antonio ^c   Paradisi, Andrea ^d   Capizzi, Rodolfo ^d   Paradisi, Mauro ^e   Chimenti, Sergio ^c   Taccari, Egisto ^f   Novelli, Giuseppe ^a,g,h  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g FATEBENEFRATELLI HOSPITAL   (Italy)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁱ NONE   (Italy)

Author keywords

Association study; Psoriasis; Psoriatic arthritis; PSORS2; RUNX1

Indexed keywords

DNA; PROTEIN DERIVATIVE; PSORIASIS SUSCEPTIBILITY 2 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CHROMOSOME 17Q; COHORT ANALYSIS; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; MARKER GENE; PATHOGENESIS; POPULATION; PSORIATIC ARTHRITIS; SAMPLE SIZE; SIGNAL DETECTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, PSORIATIC; COHORT STUDIES; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; ITALY; MODELS, GENETIC; POLYMORPHISM, GENETIC; PROTEINS; PSORIASIS;

EID: 33745113473     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093529     Document Type: Article

References (10)

1. Ritchlin CT: Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2005;17:406-412.
2. Gladman DD: Psoriatic arthritis. Rheum Dis Clin North Am 1998;24:829-844.
3. Gladman DD, Farewell VT, Nadeau C: Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675-679.
4. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffeman M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM: A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003;35:349-356.
5. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, Bowcock AM: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-1145.
6. Dougados M, van der Linden S, Juhlin R, Huitfeld B, Amor B, Calin A: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-1227.
7. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
8. Gudjonsson JE, Karason A, Antonsdottir AA, Runarsdottir EH, Hauksson VB, Upmanyu R, Gulcher J, Stefansson K, Valdimarsson H: HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002;118:362-365.
9. Huffmeier U, Traupe H, Burkhardt H, Shurmeier-Horst F, Lascorz J, Bohm B, Lohmann J, Stander M, Wendler J, Kelsch R, Baumann C, Kuster W, Wienker TF, Reis A: Lack of evidence for genetic association to RUNX1 binding site at PSORS2 in different German psoriasis cohort. J Invest Dermatol 2005;124:107-110.
10. Berger M, Stassen HH, Kohler K, Krane V, Monks D, Wanner C, Hoffmann K, Hoffmann MM, Zimmer M, Bickeboller H, Lindner TH: Hidden population substructures in an apparently homogeneous population bias association studies. Eur J Hum Genet 2006;14:236-244.